We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

81 hedge funds and large institutions have $404M invested in RAPT Therapeutics in 2020 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more funds holding in top 10

Funds holding in top 10: 4 → 9 (+5)

94% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 17

50% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 16

21% more funds holding

Funds holding: 67 → 81 (+14)

1.82% more ownership

Funds ownership: 8.6% → 10.41% (+1.8%)

19% less call options, than puts

Call options by funds: $2.51M | Put options by funds: $3.08M

25% less capital invested

Capital invested by funds: $536M → $404M (-$132M)

Holders
81
Holders Change
+14
Holders Change %
+20.9%
% of All Funds
1.43%
Holding in Top 10
9
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+125%
% of All Funds
0.16%
New
33
Increased
24
Reduced
16
Closed
17
Calls
$2.51M
Puts
$3.08M
Net Calls
-$571K
Net Calls Change
-$239K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$42.9M
2
KCM
Kingdon Capital Management
New York
+$6.89M
3
BlackRock
BlackRock
New York
+$5.29M
4
Millennium Management
Millennium Management
New York
+$4.4M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.03M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$18.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.4M
3
ROTUOC
Regents of the University of California
California
-$7.03M
4
GTC
Ghost Tree Capital
New York
-$3.7M
5
SSA
Schonfeld Strategic Advisors
New York
-$3.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$925K +$463K +2,128 +57%
N
27
Nuveen
North Carolina
$867K +$13K +60 +1%
Two Sigma Investments
28
Two Sigma Investments
New York
$867K +$828K +3,808 +227%
PCM
29
Pentwater Capital Management
Florida
$790K – – –
Swiss National Bank
30
Swiss National Bank
Switzerland
$711K +$978K +4,500 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$640K +$701K +3,225 +391%
Wells Fargo
32
Wells Fargo
California
$597K -$537K -2,469 -40%
Squarepoint
33
Squarepoint
New York
$554K +$763K +3,507 New
ECM
34
ExodusPoint Capital Management
New York
$509K +$241K +1,108 +52%
PHP
35
Parkman Healthcare Partners
Connecticut
$497K -$131K -604 -16%
TRSOTSOK
36
Teachers Retirement System of the State of Kentucky
Kentucky
$490K – – –
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$483K -$13.5K -62 -2%
Deutsche Bank
38
Deutsche Bank
Germany
$470K +$481K +2,211 +290%
Voloridge Investment Management
39
Voloridge Investment Management
Florida
$362K +$498K +2,290 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$327K – – –
Goldman Sachs
41
Goldman Sachs
New York
$326K +$449K +2,064 New
QI
42
QS Investors
New York
$324K +$446K +2,050 New
State of Wisconsin Investment Board
43
State of Wisconsin Investment Board
Wisconsin
$312K -$54.4K -250 -11%
Massachusetts Financial Services
44
Massachusetts Financial Services
Massachusetts
$305K +$420K +1,932 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$288K – – –
SCM
46
Sio Capital Management
New York
$282K – – –
WMRU
47
William Marsh Rice University
Texas
$281K +$387K +1,781 New
JF
48
Jump Financial
Illinois
$256K +$352K +1,620 New
JP Morgan Chase
49
JP Morgan Chase
New York
$251K +$122K +559 +54%
HP
50
Harbourvest Partners
Massachusetts
$244K +$336K +1,544 New
1
2
3 4

RAPT Hedge Fund Activity: Q4 2020 in Review

81 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2020, worth a combined $404M — down 25% from $536M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new RAPT positions and 17 closed out — a net gain of 16 holders — while 24 added to existing stakes and 16 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $42.9M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $18.5M sold.

  • 81 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2020, up from 67 in Q3 2020.
  • Funds reported $404M of RAPT Therapeutics stock for Q4 2020, down 25% quarter-over-quarter.
  • 33 funds opened new RAPT Therapeutics positions in Q4 2020 and 17 closed out, a net change of +16 holders.
  • The largest RAPT Therapeutics buyer in Q4 2020 was Perceptive Advisors, an estimated $42.9M added.
  • The largest RAPT Therapeutics seller in Q4 2020 was Avoro Capital Advisors, an estimated $18.5M sold.

Based on aggregated 13F filings for Q4 2020.